SHENZHEN, China, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen, specializing in cross-border logistics, today announced that it has entered into a strategic framework agreement with Lenovo Group and its subsidiaries, one of the world's leading technology companies and a Fortune Global 500 enterprise. The strategic framework partnership agreement establishes Jayud as a key logist ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver B.C., Nov. 05, 2025 (GLOBE NEWSWIRE) -- TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) is pleased to announce, that further to its news release dated October 20, 2025, the Company has closed its non-brokered private placement offering (the “Offering”) issuing a total of 17,641,293 units of the Company (“Units”) for gross proceeds of $2,469,781.02. Each Unit c ...

ORIGIN 3 trial primary endpoint results for Atacicept in IgA nephropathy (IgAN) selected as a featured late-breaking oral presentation during opening plenary session of American Society of Nephrology (ASN) Kidney Week 2025Biologics License Application (BLA) submission through the Accelerated Approval Program for atacicept for the treatment of IgAN to U.S. FDA expected in Q4; potential U.S. commercial launch of atacicept in 2026Actively enrolling patients in the PIONEER, atacicept monthly dose range finding, ...

NANJING, China, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The 14th Suzhou Creative and Design Cultural Industry Expo came to an end on November 2nd. This cultural gala rooted in the Jiangnan region (the southern area of the Yangtze River Delta in China), with the core theme of "Culture and Creativity Make Life More Interesting", set a new historical high in terms of exhibition scale, number of visitors and achievements - within the 41,000-square-meter exhibition hall, there were over 100,000 person-times of visits ...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, is pleased to announce a non-brokered private placement of up to approximately 30,000,000 units (“Units”) of the Company at a price of $0.025 per Unit for aggregate gross proceeds of up to appr ...

Revenue of $53.1 million, up 5% year over year, above the midpoint of guidancePositive adjusted EBITDA of $1.1 million or 2% adjusted EBITDA marginContinued to generate cash from operationsExpansion of Apollo and Atlas MAX PLUS installations, driving growth in bulk apparel productionAnnual recurring revenue from AIC grew to $21.5 million in Q3 and $23.1 million to date, reflecting continued adoption of Kornit’s usage-based revenue model ROSH-HA`AYIN, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Kornit Digital ...

The Aerostream BUCs are designed to enable robust, high-speed In-Flight Connectivity across both LEO and GEO satellitesPETAH TIKVA, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that its Commercial Division received an order of $7 million for Gilat Wavestream’s Aerostream 60W Ka-band Wideband BUCs. These units will be deployed as part of a next-generation In-Fl ...

ZUG, Switzerland, November 5, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on advancing therapies to address significant unmet needs in inflammatory skin and joint diseases, today announced the pricing of an underwritten offering of 7,142,857 Class A ordinary shares at an offering price per share of $10.50. The gross proceeds from the offering to MoonLake, before deducting the underwriting discounts and commissions and other offering expenses ...

During 12-week post-treatment period, nimacimab plus semaglutide blunts weight regain compared to semaglutide alone in subset analysisSAN DIEGO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will present a late-breaking oral presentation at ObesityWeek 2025 on November 7, 2025, in Atlanta, Georgia. The presentation w ...

MINNEAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, November 12, 2025. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update. Webcast and Conference Call Information To participate i ...